BioSpace News Archive

Business

Blast off! Ribon Therapeutics and Hans Bishop’s Sana Biotechnoloy Officially Launch

On opposite sides of the country, the two new companies tackle different methods to treat disease.

January 4, 2019
·
3 min read
·
Alex Keown
Drug Development

Selecta Biosciences’ New CEO Restructures, Cuts 36% of Staff

Selecta Biosciences announced that as part of restructuring efforts it is cutting its current workforce by 36 percent. The company believes that the cuts, along with a reprioritization of its pipeline, will decrease its yearly cash burn by 19 percent.

January 4, 2019
·
2 min read
·
Mark Terry
Bio NC

Aeroflow Healthcare Reports Significant Growth Metrics Spanning Revenue and Employee Satisfaction in 2018

Aeroflow Healthcare, an Inc. 5000 fastest growing company, today announced that 2018 lived up to the “Our Best Year Yet” theme announced just one year ago, by exceeding its goals with record-breaking sales, increased employee satisfaction and retention,

January 4, 2019
·
2 min read
Business

Let’s Make a Deal: Veracyte & J&J, Vertex & Arbor, Esperion & Daiichi Sankyo and More

With the holidays over and the JP Morgan Healthcare Conference next week, companies were clearly revving their engines, ready to race into the new year. Here’s a roundup of some of the top deals that were announced today.

January 4, 2019
·
4 min read
·
Mark Terry
Business

BioNTech Teams up With Sanofi to Target Solid Tumors in $91.5 Million Deal

Days ahead of the J.P. Morgan Healthcare Conference, Germany-based BioNTech extended its three-year-old collaboration with Sanofi as the companies look to co-develop the first cancer immunotherapy candidate for solid tumors.

January 4, 2019
·
3 min read
·
Alex Keown
Biotech Bay

Six Things to Watch for at the JP Morgan Healthcare Conference

The JP Morgan Healthcare Conference, being held from January 7 through 10 at the Westin St. Francis Hotel in San Francisco, is one of the premier, possible the premier, conferences for the biopharmaceutical industry.

January 4, 2019
·
5 min read
·
Mark Terry
Job Trends

BMS CEO Giovanni Caforio Lays out Reasoning for $74 Billion Acquisition of Celgene

Over the past decade, BMS has been no stranger to flexing its M&A muscle. The company made numerous focused-acquisitions that have positioned itself as a leader in oncology. BMS CEO Giovanni Caforio noted that the massive deal for Celgene is another piece to that puzzle.

January 4, 2019
·
3 min read
·
Alex Keown
Business

AbbVie Forges $105 Million+ CD39 Inhibitor Alliance With Tizona

Privately-held Tizona Therapeutics snagged $105 million in upfront cash as its cancer antibody TTX-030 is the centerpiece of a collaborative effort with Illinois-based AbbVie.

January 4, 2019
·
2 min read
·
Alex Keown
Job Trends

Exclusive: Here’s What’s Happening in the California Life Sciences Job Market

California’s life science sector is a major player in the state’s job creation and economic development. In 2016, life science companies in California employed more than 360,000 professionals.

January 4, 2019
·
6 min read
·
Angela Rose
Job Trends

Top 12 Life Sciences Companies Hiring Now in 2019

It’s a new year! Is one of your New Year’s resolutions to find a new job? Jump start your job search now and check out top companies who are looking for quality candidates in 2019!

January 4, 2019
·
1 min read
·
Editorial Staff